Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1093 | 993 | 1093 | 1185 | 1262 | 1817 |
Fund Return | 9.34% | -0.66% | 9.34% | 5.83% | 4.76% | 6.15% |
Place in category | 216 | 279 | 216 | 217 | 175 | 85 |
% in Category | 36 | 45 | 36 | 40 | 37 | 24 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
HSBC American Index Fund Retail Acc | 16.95B | 27.03 | 11.92 | 15.17 | ||
HSBC American Index Fund Accumulati | 16.95B | 26.95 | 11.32 | 15.13 | ||
HSBC American Index Fund Income C | 16.95B | 26.93 | 11.31 | 15.12 | ||
HSBC American Index Fund Retail Inc | 16.95B | 26.83 | 11.70 | 15.15 | ||
HSFund Institutional Accumulation | 16.95B | 26.99 | 11.36 | 15.19 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Index Unit Trust Accumulation | 15.13B | 9.33 | 5.76 | 6.10 | ||
All Share Index Unit Trust Income | 15.13B | 9.33 | 5.75 | 6.09 | ||
VG UK Plus GBP Accumulation | 15.13B | 9.34 | 5.76 | 6.12 | ||
VG UK Institutional Plus GBP Income | 15.13B | 9.34 | 5.75 | 6.11 | ||
UK Equity Tracker Fund D Acc | 12.27B | 9.28 | 6.08 | 6.28 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
AstraZeneca | GB0009895292 | 6.56 | 11,784.0 | +5.91% | |
Shell | GB00BP6MXD84 | 6.44 | 32.29 | +0.99% | |
HSBC | GB0005405286 | 5.97 | 843.40 | +2.05% | |
Unilever | GB00B10RZP78 | 4.68 | 56.08 | +0.75% | |
Relx | GB00B2B0DG97 | 2.84 | 4,046.00 | +0.37% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review